How Does the Syndromic Approach Support Diagnostic Stewardship?
Getting actionable laboratory results into the hands of healthcare providers faster can lead to better patient management decisions, including diagnosis and treatment decisions. Syndromic testing with the BioFire® FilmArray® System can empower diagnostic stewards to choose the right test, the first time.
When patients present with infectious diseases with nonspecific symptoms, syndromic testing optimizes the initial evaluation and may help avoid the additional testing that comes with individual and serial tests. Instead of relying on culture, the BioFire System uses multiplex PCR testing to target a comprehensive grouping of possible causes of infection and antimicrobial resistance genes.
A syndromic approach to infectious disease testing provides pathogen-specific results in about an hour, which can facilitate targeted, rather than broad-spectrum, antibiotic treatment sooner. Identifying antimicrobial resistance genes can also help promote antibiotic stewardship when it matters most. Additionally, in collaboration with BioFire System tests in the United States, BioFire® Syndromic Trends collects pathogen-specific data that can help healthcare facilities make data-driven diagnostic stewardship plans.
As the need for effective diagnostic stewardship only becomes more critical and more urgent, the good news is that the diagnostic tools and technologies, as well as the innovative institutional practices, that are available to healthcare providers are improving by the day.